SCHEMBL21632550

SCHEMBL21632550

COC(=O)c1cnc2[nH]cc(Br)c2c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 5/20 0.41
MAP2K1 Q02750 1/20 0.40
SOS1 Q07889 1/20 0.38
NR4A2 P43354 3/20 0.37
JAK3 P52333 1/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
AKT1 P31749 1/20 0.35
CREBBP Q92793 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TTBK1 Q5TCY1 1/20 0.34
TTBK2 Q6IQ55 1/20 0.34
MAPT P10636 1/20 0.33
NEK1 Q96PY6 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31403660 1.00 AXL (0.41) AXLMAP2K1SOS1NR4A2JAK3
SCHEMBL31089858 0.75 JAK1 (0.42) JAK3
SCHEMBL25088402 0.74 NR4A2 (0.49) AXLMAP2K1NR4A2JAK3CREBBP
SCHEMBL21632480 0.73 MAPK1 (0.36) AXL
SCHEMBL26965747 0.73 MAPK1 (0.38) AXL
SCHEMBL29660550 0.73 MAPK1 (0.38) AXL
SCHEMBL31403744 0.72 AXL (0.44) AXLMAP2K1NR4A2JAK3TSHR
SCHEMBL22553986 0.71 MAP2K1 (0.56) AXLMAP2K1NR4A2JAK3CREBBP
SCHEMBL21632535 0.71 JAK3 (0.46) AXLMAP2K1JAK3TTBK1TTBK2
SCHEMBL31403683 0.71 JAK3 (0.46) AXLMAP2K1JAK3TTBK1TTBK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076284-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME DELPHIA THERAPEUTICS, INC. (US) 2025-04-10 WO disclosed
WO-2020023393-A1 KINASE ANTAGONISTS AND METHODS FOR MAKING AND USING THEM BIOBLOCKS, INC. (US) 2020-01-30 WO disclosed
WO-2020023393-A1 KINASE ANTAGONISTS AND METHODS FOR MAKING AND USING THEM BIOBLOCKS, INC. (US) 2020-01-30 WO disclosed